PETS at ICPE 2022
Recap: PETS at ICPE 2022

Faculty and staff from the Center for Pharmacoepidemiology and Treatment Science attended the International Society of Pharmacoepidemiology’s annual conference…

Drug Used for Sleep Disorders Is Linked to Higher Risk of Overdose in Teens, Young Adults

IFH’s Greta Bushnell analyzes which treatments for sleep disorders are associated with higher risk of overdose.

Howard Leventhal
Howard Leventhal Scholarship for Trainees

The deadline to apply for the scholarship award is January 13, 2023.

Outpatient Visits Are Critical to Success of Treating Opioid-Use Disorder, Researchers Find

Dr. Stephen Crystal and IFH researchers examine importance of outpatient visits for patients in treatment for opioid use.

IFH Newsletter Q3 2022

Read the latest news from the Institute for Health!

Young Women Who Reduce Binge Drinking Could Decrease Risk of COVID-19 Infection, Study Shows

IFH’s Tammy Chung, Carolyn Sartor, Ashley Grosso + Yanping Jiang found a connection between young women who binge drink and their risk of COVID-19 infection.

Tobias Gerhard Named President of International Society of Pharmacoepidemiology

IFH Interim Director, Tobias Gerhard, was installed as ISPE President at ISPE’s annual conference in August.

New RCMAR Leadership

The Rutgers Asian Resource Center for Minority Aging Research (RCMAR) appoints new leadership.

Zeeshan Ahmed
No One-Size-Fits-All Artificial Intelligence Approach Works for Prevention, Diagnosis or Treatment Using Precision Medicine

Dr. Zeeshan Ahmed leads one of the first studies examining artificial intelligence and precision medicine.

Chintan Dave
Rutgers Will Conduct the Most Comprehensive Study Ever Done of High-Risk Children Newly Diagnosed with Type 1 Diabetes

Dr. Chintan Dave will lead researchers in conducting the largest study of children at risk of developing a life-threatening complication of Type 1 diabetes.

1 2 8 9 10 19 20